In addition, overexpression of CTLA-4 has been found in several malignant cancer cell lines including melanoma, colon cancer, breast cancer, neuroblastoma, and osteosarcoma [65], which produces an opportunity for targeted therapy. This evidence concerns the gene CTLA4 and cancer.